Augustine Lawlor - Aug 9, 2021 Form 4 Insider Report for Cardiovascular Systems Inc (CSII)

Role: Director
Signature: /s/ Andrew Nick as Attorney-in-Fact for Augustine Lawlor pursuant to Power of Attorney filed herewith.
Stock symbol: CSII
Transactions as of: Aug 9, 2021
Transactions value $: $0
Form type: 4
Date filed: 8/11/2021, 07:19 PM
Previous filing: Jul 2, 2021
Next filing: Oct 5, 2021

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	CSII	Common Stock	Award	$0	+1.71K	+81.82%	$0.00	3.8K	Aug 9, 2021	Direct	F1
holding	CSII	Common Stock						25.3K	Aug 9, 2021	By Lawlor Family Trust	F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	CSII	Restricted Stock Units	Award	$0	+3.81K		$0.00	3.81K	Aug 9, 2021	Common Stock	3.81K		Direct	F4
holding	CSII	Restricted Stock Units						90.8K	Aug 9, 2021	Common Stock	90.8K		Direct	F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents restricted stock received at the election of the reporting person, in lieu of cash payment, as a retainer for service as a director of the Company during fiscal year 2022.
F2	On August 26, 2020, the reporting person transferred 25,318 shares of Company common stock to a family trust of which the reporting person's spouse is co-trustee. The reporting person's spouse and members of his immediate family are the beneficiaries of the trust.
F3	Each restricted stock unit represents the right to receive a payment from the Company equal in value to the market price per share of Company common stock on the date of payment and shall be payable in cash or shares of Company common stock beginning six months following the termination of the reporting person's board membership.
F4	Each restricted stock unit represents the right to receive a payment from the Company equal in value to the market price per share of Company common stock on the date of payment and shall be payable in cash or shares of Company common stock beginning six months following the termination of the reporting person's board membership; provided, however, that the restricted stock units vest in quarterly amounts of 954 shares on each of September 30, 2021 and December 31, 2021 and as to 953 shares on each of March 31, 2022 and June 30, 2022.